Promising Coronavirus Vaccine Resumes Trials After Brief Pause

Clinical trials for one of the world’s most promising coronavirus vaccines have resumed after a brief pause because of safety concerns.

AstraZeneca announced Saturday that phase three trials for its vaccine candidate have begun again in the United Kingdom following a review of safety data. The pharmaceutical company said Tuesday that the pause was the result of a volunteer experiencing an unexplained illness. 

“AstraZeneca is committed to the safety of trial participants and the highest…

Read Full Article

LEAVE A REPLY

Please enter your comment!
Please enter your name here